Efficacy of folicacm prophylaxis for the prevention of neural tube defects

Mental Retardation and Developmental Disabilities Research Reviews

Volumn 4, Issue 4, 1998, Pages 282-290

  Watkins, Margaret L ^a,b  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Anencephaly; Efficacy; Folie acid; Meningomyelocele; Neural tube defects; Prevention; Spina bifida; Vitamins

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHIONINE;

ANENCEPHALUS; CEREAL; CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; FOLATE METABOLISM; HUMAN; MENINGOMYELOCELE; NEURAL TUBE DEFECT; PRIORITY JOURNAL; REVIEW; SPINA BIFIDA; VITAMIN INTAKE;

EID: 0032422094     PISSN: 10804013     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2779(1998)4:4<282::AID-MRDD7>3.0.CO;2-6     Document Type: Article

References (80)

1. Beresford SAA. Annotation: How do we get enough folic acid to prevent some neural tube defects? Am J Public Health 1994;84:348350.
2. Botto LD, Khoury MJ, Mulinare J, et al. Periconceptional multivitamin use and the occurrence of conotnmcal heart defects: Results from a population-based, case-control study. Pediatrics 1996;98:911-917.
3. Bower C, Stanley FJ. Dietary folate as a risk factor for neural-tube defects: Evidence from a case-control study in Western Australia. Med JAust 1989;150:613-619.
4. Bower C, Wald NJ. Vitamin B12 deficiency and the fortification of food with folic acid. Eur J Clin Nutrl995;49:787-793.
5. Bower C, Knowles S, Nicol D. Changes in folate supplementation, and in serum and red cell folate levels in antenatal patients over the course of a health promotion project for the prevention of neural tube defects. Aust N Z J Obstet Gynaecol 1997;37:267-271.
6. Brown JE, Jacobs DR, Hartman TJ, et al. Predictors of red cell folate level in women attempting pregnancy-. JAMA 1997;277:548-552.
7. Bum J, Fisk NM. Terathanasia, folic acid and birth defects. Lancet 1997;350:1322-1323.
8. Centers for Disease Control and Prevention. Use of folic acid for prevention of spina bifida and other neural tube defects-1983-1991. MMWR 1991;40:513-516.
9. Centers for Disease Control and Prevention. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR 1992;41: 1-7.
10. Centers for Disease Control and Prevention. Prevention program for reducing risk for neural tube defects-South Carolina, 19921994. MMWR 1995a;44:141-142.
11. Centers for Disease Control and Prevention. Knowledge and use of folic acid by women of childbearing age-United States, 1995. MMWR 1995b;44:716-718.
12. Centers for Disease Control and Prevention. Knowledge and use of folic acid by women of childbearing age-United States, 1997. MMWR 1997:46:721-723.
13. Centers for Disease Control and Prevention. Use of folic acid-containing supplements among women of childbearing age-United States, 1997. MMWR 1998:47:131-134.
14. Clark NAC, Fisk NM. Minimal compliance with the Department of Health recommendation for routine folate prophylaxis to prevent fetal neural tube defects. Br J Obstet Gynaecol 1994:101:709-710.
15. Coehlo CND, Klein N. Methionine and neural tube closure in cultured rat embryos: Morphological and biochemical analyses. Teratology 1990:42:437-451.
16. Coehlo CND, Weber JA, Klein NW, et al. Whole rat embryos require methionine for neural tube closure when cultured on cow serum. J Nutr 1989;! 19:1716-1725.
17. Cornell MC, Erickson JD. Comparison of national policies on periconceptional use of folic acid to prevent spina bifida and anencephaly (SBA). Teratology 1997;55:134-137.
18. Cragan JD, Roberts HE, Edmonds LD, et al. Surveillance for anencephaly and spina bifida and the impact of prenatal diagnosis-United States, 1985-1994. MMWR CDC Surveill Summ 1995;44(No. SS-4):1-13.
19. Cuskelly GJ, McNulty H, Scott JM. Effect of increasing dietary folate on red-cell folate: Implications for prevention of neural tube defects. Lancet 1996;347:657-659.
20. Czeizel AE. Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am J Med Genet 1996;62:179-183.
21. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992:327:1832-1835.
22. Daly LE, Kirke PN, Molloy A, et al. Folate levels and neural tube defects. Implications for prevention. JAMA 1995:274:1698-1702.
23. Daly S, Mills JL, Molloy AM, et al. Minimum effective dose of folic acid for food fortification to prevent neural-tube defects. Lancet 1997:350:1666-1669.
24. Dickinson CJ. Does folic acid harm people with vitamin B,2 deficiency? QJ Med 1995:88:357364.
25. Eissein FB, Wannberg SL. Methionine but not folinic acid or vitamin B-12 alters the frequency of neural tube defects in Axd mutant mice. J Nutr 1993;123:27-34.
26. Ehvood M, Elwood H, Little J. Diet. In: Elwood JM, Little J, Elwood JH, eds. epidemiology and Control of Neural Tube Defects. Oxford: Oxford University Press, 1992:521-603.
27. Food and Drug Administration. Food standards: Amendment of standards of identity for enriched grain products to require addition of folic acid. Fed Register 1996;61:8781-8797.
28. Forman R, Singal N, Perelman V, et al. Folic acid and prevention of neural tube defects: A study of Canadian mothers of infants with spina bifida. Clin Invest Med 1996:19:195-201.
29. Gregory J. The bioavailability of folate. In: Daily L, ed. Folate in Health and Disease. New York: Marcel Dekker, 1995:195-235.
30. Hall JG. Terathanasia, folic acid and birth defects. Lancet 1997;350:1322.
31. Hall JG. Genetics of neural tube defects. Ment Ret Dev Dis Res Rev 1998; this issue.
32. Herbert V. Recommended dietary intakes (R.D.I.) of folate in humans. Am J Clin Nutr 1987:45:661-670.
33. Herbert V, Bigaouette J. Call for endorsement of a petition to the Food and Drug Administration to always add vitamin B-12 to any folate fortification or supplement. Am J Clin Nutr 1997;65:572-573.
34. Herbert VD, Colman N. Folic acid and vitamin Bi2. In: Shils ME, Young VR, eds. Modern Nutrition in Health and Disease. 7th ed. Philadelphia: Lea & Febiger, 1988:388-416.
35. Hibbard BM. The role of folic acid in pregnancy with particular reference to anemia, abruption and abortion. J Obstet Gynaecol Br Commomv 1964:71:529.
36. Hook EB, Czeizel AE. Can terathanasia explain the protective effect of folic acid supplements on birth defects? Lancet 1997;350:513-515.
37. Institute of Medicine, National Academy of Sciences. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington, DC: National Academy Press, 1998:8-1-8-45.
38. Kelly AE, Haddix AC, Scanion KS, et al. Costeffectiveness of strategies to prevent neural tube defects. In: Gold MR, Siegel JE, Russell LB, et al., eds. Cost Effectiveness in Health and Medicine. New York: Oxford University Press, 1996:313-348.
39. Kirke PN, Molloy AM, Daly LE, et al. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med 1993:86:703-706.
40. Laurence KM, James N, Miller MH, et al. Double-blind randomized controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. Br Med J [Clin Res] 1981;282:1509-1511.
41. Li DK, Daling JR, Mueller B A, et al. Periconceptional multivitamin use in relation to the risk of congenital urinary tract anomalies. Epidemiology 1995:6:212-218.
42. McNulty H. Folate requirements for health in different population groups. Br J Biomcd Sei 1995:52:110-119.
43. Medical Research Council Vitamin Study Research Group. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. Lancet 1991;338:131-137.
44. Mills JL, Rhoads GG, Simpson JL, et al. The absence of a relation between the periconceptional use of vitamins and neural-tube defects. N Engl J Med 1989;321:430-435.
45. Mills JL, McPartlin JM, Kirke PN, et al. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 1995:345:149-151.
46. Milunsky A, Jick H, Jick SS, et al. Multivitamin/ folie acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 1989;262:2847-2852.
47. Milunsky A, Jick H, Jick SS, et al. Vitamins during pregnancy and neural tube defects [letter]. JAMA 1990;263:2748-2749.
48. Mitchell HK, Snell EE, Williams RJ. The concentration of "Folk Acid." J Am Chem Soc 1941;63:2284.
49. Mulinare J, Cordero JF, Erickson JD, et al. Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA 1988:260:3141-3145.
50. Nevin NC, Seller MJ. Prevention of neural-tube defect recurrences. Lancet 1990;335:178179.
51. Nosel PG, Klein NW. Methionine decreases the embryo-toxicity of sodium valproate in the rat: In vivo and in vitro observations. Teratology 1992;46:499-507.
52. Oakley GPO, Erickson JD, Adams MJ. Urgent need to increase folk acid consumption. JAMA 1995:274:1717-1718.
53. Oakley GPO, Adams MJ, Dickinson C. More folic acid for everyone, now.J Nutr 1996; 126:751755.
54. Romano PS, Waitzman NJ, Scheffler RM, et al. Folic acid fortification of grain: An economic analysis. Am J Public Health 1995:85:667676.
55. Sayers GM, Hughes N, Scallan E, et al. A survey of knowledge and use of folic acid among women of child-bearing age in Dublin. J Public Health Med 1997;19:328-332.
56. Schorah CJ, Smithells RW, ScottJ. Vitamin B12 and anencephaly. Lancet 1980;1:880.
57. Schorah CJ, Smithells RW, Seller MJ. Terathanasia, folic acid and birth defects. Lancet 1997;350: 1323.
58. Scott JM, Weir DG, Molloy A, et al. Folic acid metabolism and mechanisms of neural tube defects. Ciba Found Symp 1984;181:180191.
59. Shaw GM, Schauer D, Velie EM, et al. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects in California. Epidemiology 1995a;6:219-226.
60. Shaw GM, Lammer EJ, Wasserman CR, et al. Risks of orofacial clefts in children boni to women using multivitamins containing folic acid periconceptionally. Lancet 1995b;346:393396.
61. Shaw GM, Velie EM, Schaffer D. Risk of neural tube defect-affected pregnancies among obese women. JAMA 1996;275:1093-1096.
62. Shaw GM, Velie EM, Schaffer D. Is dietary intake of methionine associated with a reduction in risk for neural tube defect-affected pregnancies? Teratology 1997;56:295-299.
63. Smithells RW, Sheppard S, Schorah CJ. Vitamin deficiencies and neural-tube defects. Arch Dis Child 1976;51:944.
64. Smithells RW, Sheppard S, Schorah CJ, et al. Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet 1980;1:339-340.
65. Smithells RW, Seller MJ, Harris R, et al. Further experience of vitamin supplementation for prevention of neural-tube defect recurrences. Lancet 1983;1:1027-1031.
66. Smithells RW, Sheppard S, Wild J, et al. Prevention of neural tube defect recurrences in Yorkshire: Final report. Lancet 1989;2:498-499.
67. Steegers-Theunissen RPM, Boers GHJ, Trijbels FJM, et al. Matemal hyperhomocysteinemia: A risk factor for neural-tube defects. Metabolism 1994:43:1475-1480.
68. Steegers-Theunissen RPM, Boers GHJ, Blom HJ, et al. Neural tube defects and elevated homocysteine levels in amniotic fluid. Am J Obstet Gynecol 1995:172:1436-1441.
69. Subar AF, Block G, James LD. Folate intake and food sources in the US population. Am J Clin Nutr 1989:50:508-516.
70. Thiersch JB. Therapeutic abortion with folic acid antagonist, 4-aminopteroyIglutamic acid (4amino PGA), administered the oral route. Am J Obstet Gynecol 1952:63:1298-1304.
71. Tolarova M, Harris J. Reduced recurrence of orofacial clefts after periconceptional supplementation with high-dose folic acid and multivitamins. Teratology 1995;51:71-78.
72. Vergel RG, Sanchez LR, Heredero BL, et al. Primary prevention of neural tube defects with folic acid supplementation: Cuban experience. Prenat Diagn 1990;10:1027-1031.
73. Wald N. The B4-you-conceive pill [letter]. Lancet 1996:348:1460.
74. Wald N, Hackshaw A. Folic acid and prevention of neural tube defects. Lancet 1997;350:665.
75. Waller DK, Mills JL, Simpson JL, et al. Are obese women at higher risk for producing malformed offspring? Am J Obstet Gynecol 1994:170:541-548.
76. Watkins ML, Scanlon KS, Mulinare J, et al. Is maternal obesity a risk factor for anencephaly and spina bifida? Epidemiology 1996;7:507512.
77. Werler MM, Shapiro S, Mitchell AA. Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA 1993:269:12571261.
78. Werler MM, Louik C, Shapiro S, et al. Prepregnant weight in relation to risk of neural tube defects. JAMA 1996:275:1089-1092.
79. Wild J, Sutliffe M, Schorah CJ, et al. Prevention of neural-tube defects. Lancet 1997;350:30-31.
80. Wills L, Mehta MM. Studies in "pernicious anemia" of pregnancy. Part 1. Preliminary report. Indian J Med Res 1930;17:777-792.